Reading Time: 5 minutesA clinical trial of Jedi proportions… The MND Association is backing a new clinical trial in MND, known as MIROCALS. This will be a joint
Category: Clinical Trials
Reading Time: 3 minutesThe MND Association’s Director of Research, Brian Dickie explains more about ‘GM6’, also known as ‘GM604’, a drug in development by an American pharmaceutical company
Reading Time: 4 minutesThe 25th International Symposium on ALS/MND began today in Brussels, Belgium. More than 900 delegates joined the opening session to hear Dr Alfred Sandrock from
Reading Time: 4 minutesOn 22 September 2014 Neuralstem announced the results from their long-term follow up of three participants who were involved in their initial phase I safety
Reading Time: 5 minutesA question was submitted to the Association’s AGM last weekend, which could only be answered in brief at the time, due to the number of
Reading Time: 4 minutesA number of articles were published in various news sources on 11 July 2014, highlighting how scientists in Sheffield are working towards testing a promising
Reading Time: 4 minutesThe top-line results from the Cytokinetics Inc Phase IIb clinical trial of Tirasemtiv were announced last week. Following this announcement, detailed results were then presented
Reading Time: 2 minutesA lot has been happening in terms of research policy at the moment, from the announcement of the European adaptive licensing pilot to the Government’s Early Access to
Reading Time: 4 minutesAfter a brilliant first day at ENCALS, which included a talk by Dr Johannes Brettschneider, the second day began with a talk by Thierry Latran
Reading Time: 2 minutesThe National Institute for Health Research (NIHR) has launched their ‘It’s OK to ask campaign’ which encourages patients and the public to ask about clinical research.